US Stock MarketDetailed Quotes
ARDX Ardelyx
- 5.2500
- -0.0600-1.13%
Close Nov 25 16:00 ET
1.24BMarket Cap-16406P/E (TTM)
5.5000High5.2400Low4.19MVolume5.3000Open5.3100Pre Close22.42MTurnover1.81%Turnover RatioLossP/E (Static)236.85MShares10.130052wk High7.86P/B1.21BFloat Cap4.340552wk Low--Dividend TTM231.11MShs Float35.4800Historical High--Div YieldTTM4.90%Amplitude0.4902Historical Low5.3570Avg Price1Lot Size
Ardelyx Stock Forum
Sign in to post a comment
$Ardelyx (ARDX.US)$ There's nothing to worry about folks, just buy the dip
4
$Ardelyx (ARDX.US)$
The price drop was caused by a perfect storm of negative factors. In pre-market trading hours, one or more whales received word of the court decision ahead of most other investors: probably through Barchart and premium terminal services (or boots-on-the-ground observers). If you look at the volume chart, most of the trade volume occurred very early, and the daily trading volume is well over 4x the daily average.
Because there was this big ...
The price drop was caused by a perfect storm of negative factors. In pre-market trading hours, one or more whales received word of the court decision ahead of most other investors: probably through Barchart and premium terminal services (or boots-on-the-ground observers). If you look at the volume chart, most of the trade volume occurred very early, and the daily trading volume is well over 4x the daily average.
Because there was this big ...
6
$Ardelyx (ARDX.US)$
Ardelyx Responds to District Court Decision Granting Motion to Dismiss
Ardelyx Responds to District Court Decision Granting Motion to Dismiss
$Ardelyx (ARDX.US)$ what is going on
1
2
$Ardelyx (ARDX.US)$ ardx out for a rip today
$Ardelyx (ARDX.US)$ resurrected
1
$Ardelyx (ARDX.US)$ Ardelyx Presents Results from its IBS in America 2024 Supplemental Survey at the American College of Gastroenterology's (ACG) Annual Meeting
6 MINUTES AGO, 4:05 PM EDT
VIA GLOBENEWSWIRE
Ninety percent of survey participants reported "some" or "significant" negative impact of IBS-C on their life
Survey results presented in two poster presentations
6 MINUTES AGO, 4:05 PM EDT
VIA GLOBENEWSWIRE
Ninety percent of survey participants reported "some" or "significant" negative impact of IBS-C on their life
Survey results presented in two poster presentations
1
3
️
2
$Ardelyx (ARDX.US)$ this one's gonna boom soon you'll don't even know
1
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Tom’s Jerry : Why do you have so much faith in this stock? Is there any advantage that we don't know about?
Richard Fain Fan OP Tom’s Jerry : Yeah. An over reaction by pussy retail investors, we’ll take it to the Supreme Court. fundamentals still there. Top drug not even priced in. Trading at only 2x multiples. Big money gobbling this up.
交流道的小赢熊 : Yes. Long term investors of ARDX will know this move downwards is nothing. We have been through worse with it than this.
Buy and be patient. You'll be rewarded in future.
Richard Fain Fan OP 交流道的小赢熊 : Exactly, I know the company very well and what I'm holding